Cargando…

A comparative analysis of tioguanine versus low‐dose thiopurines combined with allopurinol in inflammatory bowel disease patients

BACKGROUND: Both tioguanine and low‐dose thiopurines combined with allopurinol (LDTA) can be considered for the treatment of inflammatory bowel disease (IBD) when conventional thiopurines fail due to adverse events. AIM: To compare the safety of tioguanine and LDTA in IBD patients. METHODS: Inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biemans, Vince B. C., Savelkoul, Edo, Gabriëls, Ruben Y., Simsek, Melek, Dijkstra, Gerard, Pierik, Marieke J., West, Rachel L., de Boer, Nanne K.H., Hoentjen, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318327/ https://www.ncbi.nlm.nih.gov/pubmed/32339331 http://dx.doi.org/10.1111/apt.15730

Ejemplares similares

Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol–thiopurine cotherapy
por: Simsek, Melek, et al.
Publicado: (2018)

Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn’s Disease
por: Savelkoul, E H J, et al.
Publicado: (2022)

Two Brothers with Skewed Thiopurine Metabolism in Ulcerative Colitis Treated Successfully with Allopurinol and Mercaptopurine Dose Reduction
por: Hoentjen, Frank, et al.
Publicado: (2011)

Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease
por: Simsek, Melek, et al.
Publicado: (2017)

Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
por: Meijer, Berrie, et al.
Publicado: (2017)

Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro
por: Broekman, Mark M. T. J., et al.
Publicado: (2015)

Safety and Efficacy of Split-Dose Thiopurine vs Low-Dose Thiopurine-Allopurinol Cotherapy in Pediatric Inflammatory Bowel Disease
por: Cococcioni, Lucia, et al.
Publicado: (2022)

Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapies
por: Simsek, Melek, et al.
Publicado: (2019)

Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis
por: Kverka, Miloslav, et al.
Publicado: (2011)

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands
por: van den Brand, Floris F., et al.
Publicado: (2018)

How I treat my inflammatory bowel disease-patients with thiopurines?
por: Meijer, Berrie, et al.
Publicado: (2016)

Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre cohort study
por: Asscher, Vera E. R., et al.
Publicado: (2020)

Influence of allopurinol on thiopurine associated toxicity: A retrospective population‐based cohort study
por: Houwen, Jeroen P.A., et al.
Publicado: (2020)

Rac Attack: Modulation of the Small GTPase Rac in Inflammatory Bowel Disease and Thiopurine Therapy
por: Seinen, Margien L., et al.
Publicado: (2016)

Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency
por: Deben, Debbie S., et al.
Publicado: (2023)

Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD
por: Moreau, Brigitte, et al.
Publicado: (2017)

Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2020)

Off‐label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis
por: Simsek, Melek, et al.
Publicado: (2019)

Vedolizumab for Inflammatory Bowel Disease: Two‐Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry – Vedolizumab
por: Biemans, Vince B.C., et al.
Publicado: (2019)

Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2021)

Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy
por: Jansen, Fenna M., et al.
Publicado: (2023)

Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2022)

Management of Crohn’s disease in poor responders to adalimumab
por: de Boer, Nanne KH, et al.
Publicado: (2014)

Golimumab for the treatment of ulcerative colitis
por: Löwenberg, Mark, et al.
Publicado: (2014)

Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases
por: van Liere, Elsa L. S. A., et al.
Publicado: (2021)

Thiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel disease
por: Gazouli, Μaria, et al.
Publicado: (2012)

Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatment
por: Biemans, Vince B. C., et al.
Publicado: (2020)

Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study
por: Jagt, Jasmijn Z., et al.
Publicado: (2021)

Pharmacology of Thiopurine Therapy in Inflammatory Bowel Disease and Complete Blood Cell Count Outcomes: A 5-Year Database Study
por: Meijer, Berrie, et al.
Publicado: (2017)

Advances in Thiopurine Drug Delivery: The Current State-of-the-Art
por: Bayoumy, Ahmed B., et al.
Publicado: (2021)

Use of thiopurines in inflammatory bowel disease: an update
por: Singh, Arshdeep, et al.
Publicado: (2022)

Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease
por: Zakerska-Banaszak, Oliwia, et al.
Publicado: (2022)

Thioguanine is Effective as Maintenance Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Registry Study
por: Simsek, Melek, et al.
Publicado: (2023)

Prediction of Inflammatory Bowel Disease Course Based on Fecal Scent
por: Bosch, Sofie, et al.
Publicado: (2022)

Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells – Effects on gene expression levels and thiopurine metabolism
por: Haglund, Sofie, et al.
Publicado: (2017)

Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
por: Biemans, Vince B C, et al.
Publicado: (2020)

Thiopurine metabolite level and toxicity in Indians with inflammatory bowel disease
por: Parkar, Suruchi P, et al.
Publicado: (2017)

Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
por: Cornish, Jack S., et al.
Publicado: (2020)

Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
por: Tominaga, Keiichi, et al.
Publicado: (2021)

Pharmacogenetics of thiopurine therapy: from thiopurine S-methyltransferase to S-adenosylmethionine
por: Mlinarič-Raščan, Irena, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7trdgelnili4sqoetu59fid79f